At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
HSCS HeartSciences Inc
Pre-Mkt 06-09 06:47:58 EDT
1.84
-0.10
-5.15%
盘前1.96
+0.12+6.52%
06:04 EDT
High1.90
Low1.80
Vol24.10K
Open1.88
D1 Closing1.94
Amplitude5.15%
Mkt Cap5.85M
Tradable Cap5.63M
Total Shares3.18M
T/O44.34K
T/O Rate0.79%
Tradable Shares3.06M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
HeartSciences partners with Bunkerhill Health to offer FDA-cleared ECG-EF algorithm on MyoVista Insights platform
Heart Test Laboratories, Inc., doing business as HeartSciences, is a medical technology company focuses on applying AI-based technology to an ECG to expand and improve an ECG's clinical utility. It is developing AI-ECG solutions to be made available on a hardware agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is designed to provide diagnostic information related to cardiac dysfunction. The MyoVista also provides conventional ECG information in the same test. The company was incorporated in 2007 and is headquartered in Southlake, Texas.